160 related articles for article (PubMed ID: 9693964)
1. [Clinical studies of tazobactam/piperacillin (TAZ/PIPC) in pediatric patients].
Waga S; Yokoyama M; Tsushima T; Chiba C; Saito T; Okamoto T; Asuka T; Kitazawa J; Tateyama N; Sato Y; Takahashi Y
Jpn J Antibiot; 1998 May; 51(5):305-18. PubMed ID: 9693964
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
Jpn J Antibiot; 1998 May; 51(5):325-45. PubMed ID: 9693966
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
Iwai N; Nakamura H; Miyazu M
Jpn J Antibiot; 1998 May; 51(5):346-61. PubMed ID: 9693967
[TBL] [Abstract][Full Text] [Related]
4. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
5. [Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field].
Fujii R; Okuno A; Fujita K; Yoshikawa M; Inyaku F; Takimoto M; Saijo M; Wagatsuma S; Fukushima N; Ishikawa A
Jpn J Antibiot; 1995 Mar; 48(3):311-45. PubMed ID: 7752448
[TBL] [Abstract][Full Text] [Related]
6. [Laboratory and clinical studies on tazobactam/piperacillin in the field of pediatrics].
Kuno K; Ogawa A; Hayakawa F; Miyajima Y; Takahashi H; Okumura A; Kato T; Itomi K
Jpn J Antibiot; 1998 Jun; 51(6):395-406. PubMed ID: 9755829
[TBL] [Abstract][Full Text] [Related]
7. [Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
Shinagawa N; Yura J; Mashita K; Matsuno S; Rikiyama T; Hirayama T; Tanaka T; Otsuka K; Iwai S; Nakagawa Y
Jpn J Antibiot; 1995 Mar; 48(3):346-67. PubMed ID: 7752449
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
Oizumi K; Ohno T; Kawahara M; Kawaguchi S; Saisho M; Mitutake Y; Saito A; Tomizawa M; Koike T; Takebe K
Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
[TBL] [Abstract][Full Text] [Related]
9. [Fundamental and clinical studies on tazobactam/piperacillin in the pediatric field].
Kitamura K; Nishimori H; Ihara T; Kamiya H
Jpn J Antibiot; 1998 Jun; 51(6):407-12. PubMed ID: 9755830
[TBL] [Abstract][Full Text] [Related]
10. Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.
Nishida K; Higashitani F; Hyodo A
Chemotherapy; 1997; 43(3):171-8. PubMed ID: 9142457
[TBL] [Abstract][Full Text] [Related]
11. [Development of beta-lactamase inhibitors].
Hyodo A; Higashitani F; Nishida K; Kunugita C; Unemi N
Nihon Rinsho; 1997 May; 55(5):1272-80. PubMed ID: 9155186
[TBL] [Abstract][Full Text] [Related]
12. [Clinical studies on tazobactam/piperacillin (YP-14) in the pediatric field].
Takamuro M; Watanabe A
Jpn J Antibiot; 1998 May; 51(5):319-24. PubMed ID: 9693965
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of tazobactam/piperacillin in obstetrics and gynecological infections].
Chimura T; Hirayama T
Jpn J Antibiot; 1996 Aug; 49(8):808-12. PubMed ID: 9053535
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].
Oizumi K; Kawahara M; Kawaguchi S; Sigematsu H; Tanaka F; Sano N; Saito A; Hiraga Y; Ohmichi M; Inoue H
Jpn J Antibiot; 1995 Apr; 48(4):482-513. PubMed ID: 7783314
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients].
Sudo F; Ishiwada N; Hoshino T; Fukasawa C; Inami Y; Hishiki H; Takeda N; Kurosaki T; Kohno Y
Kansenshogaku Zasshi; 2005 Sep; 79(9):637-43. PubMed ID: 16248372
[TBL] [Abstract][Full Text] [Related]
16. Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients.
Kobayashi R; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
J Microbiol Immunol Infect; 2018 Aug; 51(4):473-477. PubMed ID: 28690028
[TBL] [Abstract][Full Text] [Related]
17. [In vitro synergistic effects of tazobactam/piperacillin with various antibiotics].
Nishida K; Niidome K; Hashimoto M; Otsuki M; Nishino T
Jpn J Antibiot; 1994 Oct; 47(10):1348-62. PubMed ID: 7807695
[TBL] [Abstract][Full Text] [Related]
18. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (2)--Teratological study in rats with intravenously administration].
Sato T; Lochry EA; Hoberman AM; Christian MS
J Toxicol Sci; 1994 Oct; 19 Suppl 2():215-32. PubMed ID: 7830288
[TBL] [Abstract][Full Text] [Related]
19. [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].
Fukasawa C; Hoshino T; Kutsuna S; Sawada K; Sato H; Ishiwada N
Kansenshogaku Zasshi; 2013 Sep; 87(5):590-5. PubMed ID: 24195168
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the clinical breakpoints of piperacillin-tazobactam against infections caused by Pseudomonas aeruginosa.
Yamagishi Y; Terada M; Ohki E; Miura Y; Umemura T; Mikamo H
J Infect Chemother; 2012 Feb; 18(1):127-9. PubMed ID: 21814800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
